XNPT

XenoPort, Inc. Press Releases

$4.38
*  
0.01
0.23%
Get XNPT Alerts
*Delayed - data as of Jul. 24, 2014  -  Find a broker to begin trading XNPT now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    XNPT After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

XenoPort to Release Second Quarter Financial Results on August 6, 2014
7/22/2014 12:00:00 PM - Business Wire

XenoPort Announces Initiation of a Phase 2 Clinical Trial of XP23829 in Patients With Psoriasis
6/23/2014 8:30:00 AM - Business Wire

Stockholders Elect ALL Three XenoPort Director Nominees at Annual Meeting
6/11/2014 1:06:00 PM - Business Wire

XenoPort to Present at the 2014 Wells Fargo Healthcare Conference
6/9/2014 10:00:00 AM - Business Wire

XenoPort Urges Stockholders to Vote "FOR ALL" XenoPort Director Nominees on the WHITE Proxy Card
6/6/2014 8:30:00 AM - Business Wire

CEO Has Special Incentive to Spend on Horizant, Says Clinton Group
6/5/2014 8:44:00 AM - PR Newswire

Intersect ENT Announces Appointment of Chief Financial Officer Jeryl Hilleman
6/4/2014 8:03:00 AM - Business Wire

XenoPort Mails Letter to Stockholders Highlighting ISS’s Recommendation That XenoPort Stockholders Vote “FOR ALL” of XenoPort’s Director Nominees on the WHITE Card
6/3/2014 8:30:00 AM - Business Wire

Second Independent Proxy Advisory Firm Recommends that XenoPort Stockholders Vote “FOR ALL” XenoPort Director Nominees on the WHITE Proxy Card
6/2/2014 4:05:00 PM - Business Wire

XenoPort to Present New Pooled Data Analyses on HORIZANT (gabapentin enacarbil) at the 2014 SLEEP Annual Meeting
6/2/2014 9:33:00 AM - Business Wire

Leading Independent Proxy Advisory Firm ISS Recommends XenoPort Stockholders Vote FOR ALL XenoPort Director Nominees
5/30/2014 8:30:00 AM - Business Wire

XenoPort to Present at the Jefferies 2014 Global Healthcare Conference
5/27/2014 10:00:00 AM - Business Wire

XenoPort Board Ignores Key Issue, Says Clinton Group
5/22/2014 12:32:00 PM - PR Newswire

XenoPort Files Investor Presentation
5/21/2014 10:05:00 AM - Business Wire

XenoPort to Mail Letter to Stockholders
5/20/2014 8:30:00 AM - Business Wire

Reckitt Benckiser Pharmaceuticals and XenoPort Enter Into Global Licensing Agreement for Arbaclofen Placarbil
5/15/2014 8:00:00 AM - PR Newswire

Clinton Group Distributes Presentation to XenoPort Stockholders
5/13/2014 8:00:00 AM - PR Newswire

XenoPort to Mail Letter to Stockholders
5/9/2014 8:30:00 AM - Business Wire

XenoPort Reports First Quarter Financial Results
5/8/2014 4:10:00 PM - Business Wire

XenoPort to Release First Quarter Financial Results on May 8, 2014
5/1/2014 10:00:00 AM - Business Wire

XenoPort Presents New Analyses of Data for Gabapentin Enacarbil at the 33rd Annual Scientific Meeting of the American Pain Society
4/30/2014 8:30:00 AM - Business Wire